P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELECTIVE SMALL MOLECULE INHIBITION DELIVERS SINGLE AGENT ACTIVITY AND SYNERGISES WITH ATR INHIBITION

• C. Pfeiffer,
• P. Beer,
• H. Asnagli,
• A. Bolomsky,
• A. Grandits,
• A. Schneller,
• J. Huber,
• N. Zojer,
• M. Schreder,
• A. Parker,
• H. Ludwig

Affiliations

C. Pfeiffer

1 Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria

P. Beer

2 Step Pharma, Saint-Genis-Pouilly, France

H. Asnagli

2 Step Pharma, Saint-Genis-Pouilly, France

A. Bolomsky

3 National Cancer Institute, Center for Cancer Research, Lymphoid Malignancies Branch, National Institutes of Health, Bethesda, United States of America

A. Grandits

4 Department of Medicine I, Division of Oncology, Medical University of Vienna

A. Schneller

1 Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria

J. Huber

1 Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria

N. Zojer

1 Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria

M. Schreder

1 Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria

A. Parker

2 Step Pharma, Saint-Genis-Pouilly, France

H. Ludwig

1 Department of Medicine I, Klinik Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria